CHEMFAB Alkalis Ltd. Issues Corrigendum for 17th AGM Notice, Corrects Agenda Item Numbering
Chemfab Alkalis Limited issued a corrigendum to its 17th AGM notice scheduled for September 9, 2026. The notice corrects typographical errors in the serial numbering of special business agenda items concerning cost auditor remuneration and director commission. The AGM will discuss financial statements, dividend, auditor appointments, and director remuneration.
This is a minor correction to agenda item numbering in an AGM notice and does not materially affect the company's operations or financial performance.
The announcement is a procedural correction to an existing notice and does not contain new material financial or business information that would positively or negatively impact the company's outlook.
Chemfab Alkalis Limited has issued a corrigendum to the Notice of its 17th Annual General Meeting (AGM), which is scheduled to be held on Wednesday, 9th September 2026, at 10:00 AM IST through Video Conferencing/Other Audio-Visual Means.
This corrigendum addresses certain typographical errors identified in the serial numbering of agenda items under special business. Specifically, the agenda items previously numbered as '4. Ratification of Cost Auditor's Remuneration' and '5. Payment of Commission to Non-Executive Directors of the Company' have been corrected to '5. Ratification of Cost Auditor's Remuneration' and '6. Payment of Commission to Non-Executive Directors of the Company', respectively.
The revised Notice of the 17th AGM, with the corrected agenda item numbering, has been enclosed for records. The AGM will consider ordinary business including the adoption of financial statements, reappointment of a director retiring by rotation, declaration of dividend, and appointment of statutory auditors. Special business includes ratification of cost auditor's remuneration and payment of commission to non-executive directors.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.